Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.

MLA

Lockney, Natalie, et al. “Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.” Journal of Gastrointestinal Cancer, vol. 46, no. 4, Dec. 2015, pp. 390–98. EBSCOhost, https://doi.org/10.1007/s12029-015-9764-6.

APA

Lockney, N., Zhang, M., Lu, Y., Sopha, S., Washington, M., Merchant, N., Zhao, Z., Shyr, Y., Chakravarthy, A., & Xia, F. (2015). Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer, 46(4), 390–398. https://doi.org/10.1007/s12029-015-9764-6

Chicago

Lockney, Natalie, Manchao Zhang, Yanzhen Lu, Sabrina Sopha, M. Washington, Nipun Merchant, Zhiguo Zhao, Yu Shyr, A. Chakravarthy, and Fen Xia. 2015. “Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.” Journal of Gastrointestinal Cancer 46 (4): 390–98. doi:10.1007/s12029-015-9764-6.